Erratum To: Tumor-Infiltrating Lymphocytes and Molecular Response After Neoadjuvant Therapy for HR+/HER2− Breast Cancer: Results From Two Prospective Trials
Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-017-4219-3
Full Text
Open PDFAbstract
Available in full text
Date
April 3, 2017
Authors
Publisher
Springer Science and Business Media LLC